Wealth Alliance Exact Sciences Corp Transaction History

Wealth Alliance

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 30, 2024	SELL	$59.06 - $75.72 $20,671 - $26,502	-350 Reduced 10.2%	3,082 $228,000
Q3 2023 Nov 09, 2023	SELL	$65.94 - $99.04 $59,214 - $88,937	-898 Reduced 20.74%	3,432 $234,000
Q2 2023 Aug 02, 2023	BUY	$62.68 - $95.05 $70,515 - $106,931	1,125 Added 35.1%	4,330 $406,000
Q1 2023 May 10, 2023	BUY	$47.19 - $70.77 $151,243 - $226,817	3,205 New	3,205 $217,000
Q3 2021 Nov 12, 2021	SELL	$90.24 - $124.05 $187,608 - $257,899	-2,079 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$93.66 - $139.27 $49,265 - $73,256	526 Added 33.87%	2,079 $258,000
Q1 2021 May 18, 2021	SELL	$116.57 - $155.01 $125,196 - $166,480	-1,074 Reduced 40.88%	1,553 $205,000
Q4 2020 Feb 11, 2021	BUY	$99.61 - $142.12 $41,039 - $58,553	412 Added 18.6%	2,627 $348,000
Q3 2020 Nov 13, 2020	SELL	$72.92 - $102.01 $13,854 - $19,381	-190 Reduced 7.9%	2,215 $226,000
Q2 2020 Aug 14, 2020	BUY	$55.75 - $92.75 $134,078 - $223,063	2,405 New	2,405 $209,000

673

162M

2.58M

2.19M

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $10.2B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

Get notified when there are updates to the investment portfolio of Wealth Alliance, based on Form 13F filings with the SEC.

Stay updated on Wealth Alliance with notifications on news.